Technical Analyst Ashwani Gujral has maintained 'sell' rating on Orchid Chemicals & Pharmaceuticals Ltd stock with a target of Rs 112.

According to Mr. Singhvi, interested traders can sell the stock with stop loss of Rs 138.

Today, the stock opened at Rs 1108.85 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 1138 and a low of Rs 688 on BSE.

Current EPS & P/E ratio stood at 7.85 and 20.95 respectively.

After selling the stock, the interested investors can enter the stock again at a low price, for medium or long term prospective.

On May 05, Orchid Chemicals entered into an out-licensing and distribution deal with US-based Alvogen for eight formulations, which have a total market size of $8 billion.

Under the deal, Orchid Chemicals said that it will develop and formulate eight oral non-antibiotic formulations for licensing and selling by Alvogen in the US market.

The company, on May 18, announced that a conference of its directors will take place on May 27 in order to approve the company's audited financial results for the fiscal ended March 31, 2010.

Moreover, the directors of the company will also consider recommendation of dividend on equity capital for the financial year ended March 31, 2010.